Literature DB >> 10384091

Cutting edge: trimolecular interaction of TCR with MHC class II and bacterial superantigen shows a similar affinity to MHC:peptide ligands.

S Redpath1, S M Alam, C M Lin, A M O'Rourke, N R Gascoigne.   

Abstract

Bacterial superantigens such as Staphylococcus aureus enterotoxin A (SEA) are very potent stimulators of T cells. They bind to the Vbeta region of the TCR and to MHC class II, stimulating T cells at nanomolar concentrations. Using surface plasmon resonance measurements, we find that binding between the individual components of the complex (TCR-class II, TCR-SEA, SEA-class II) is very weak, but that the stability of the trimolecular complex is considerably enhanced, reaching an affinity similar to that found for TCR interactions with MHC:peptide ligand. Thus, the potency of SEA in stimulation of T cells is not due to particularly strong affinities between the proteins, but to a cooperative effect of interactions in the TCR-SEA-MHC class II trimolecular complex that brings the kinetics into a similar range to binding of conventional Ags. This range may be the optimum for T cell activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10384091

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition.

Authors:  Zarixia Zavala-Ruiz; Iwona Strug; Bruce D Walker; Philip J Norris; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-26       Impact factor: 11.205

2.  The structure of superantigen complexed with TCR and MHC reveals novel insights into superantigenic T cell activation.

Authors:  Maria Saline; Karin E J Rödström; Gerhard Fischer; Vladislav Yu Orekhov; B Göran Karlsson; Karin Lindkvist-Petersson
Journal:  Nat Commun       Date:  2010-11-16       Impact factor: 14.919

3.  Persistence of zinc-binding bacterial superantigens at the surface of antigen-presenting cells contributes to the extreme potency of these superantigens as T-cell activators.

Authors:  Dorothy D Pless; Gordon Ruthel; Emily K Reinke; Robert G Ulrich; Sina Bavari
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 4.  Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.

Authors:  Halina Offner; Sushmita Sinha; Chunhe Wang; Gregory G Burrows; Arthur A Vandenbark
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

5.  Superantigens hyperinduce inflammatory cytokines by enhancing the B7-2/CD28 costimulatory receptor interaction.

Authors:  Revital Levy; Ziv Rotfogel; Dalia Hillman; Andrey Popugailo; Gila Arad; Emmanuelle Supper; Farhat Osman; Raymond Kaempfer
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-05       Impact factor: 11.205

Review 6.  Thirty-six views of T-cell recognition.

Authors:  M Krummel; C Wülfing; C Sumen; M M Davis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-08-29       Impact factor: 6.237

7.  Uptake and intracellular trafficking of superantigens in dendritic cells.

Authors:  María B Ganem; Mauricio C De Marzi; María J Fernández-Lynch; Carolina Jancic; Mónica Vermeulen; Jorge Geffner; Roy A Mariuzza; Marisa M Fernández; Emilio L Malchiodi
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

Review 8.  CD28: direct and critical receptor for superantigen toxins.

Authors:  Raymond Kaempfer; Gila Arad; Revital Levy; Dalia Hillman; Iris Nasie; Ziv Rotfogel
Journal:  Toxins (Basel)       Date:  2013-09-09       Impact factor: 4.546

Review 9.  Staphylococcal enterotoxins.

Authors:  Irina V Pinchuk; Ellen J Beswick; Victor E Reyes
Journal:  Toxins (Basel)       Date:  2010-08-18       Impact factor: 4.546

10.  Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock.

Authors:  Gila Arad; Revital Levy; Iris Nasie; Dalia Hillman; Ziv Rotfogel; Uri Barash; Emmanuelle Supper; Tomer Shpilka; Adi Minis; Raymond Kaempfer
Journal:  PLoS Biol       Date:  2011-09-13       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.